Radiotherapy for arthritis in the jaw joint
Official title: Exploring Radiotherapy of Temporomandibular Joint Arthritis
Run by Medical University of Vienna · NCT05716737 · Data updated 2026-11-12
This study is testing if using radiotherapy on the jaw joint can help relieve pain and reduce side effects for people with arthritis in that area.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 50 Years to 100 Years |
| Sex | All |
| Enrollment | 10 (estimated) |
| Sponsor | Medical University of Vienna Academic / other |
| Locations | 1 site (Vienna) |
| Status | Recruiting |
| Started | July 7, 2023 |
| Main results expected | July 7, 2024 |
| Study ends | July 7, 2027 |
| Registry record updated | September 25, 2025 |
| Trial ID | NCT05716737 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals diagnosed with TMJ arthritis by a qualified oral and maxillofacial surgeon or dentist.
✕Probably not a fit
Patients who have previously received irradiation in the TMJ area or are under the age of 50 may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This pilot study aims to evaluate the acute side effects and potential pain relief resulting from radiotherapy applied to the temporomandibular joint (TMJ) in patients with arthritis. Participants will complete a symptom-oriented questionnaire and use a numeric rating scale to assess their pain levels. The feasibility of the irradiation procedure will also be examined as part of the study's methodology.
Why it matters
Potential benefit: If successful, this study could provide a new pain relief option for patients suffering from TMJ arthritis.
How similar studies have gone: While this approach is relatively novel, similar studies exploring radiotherapy for joint conditions have shown promising results.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * TMJ arthritis * diagnosed by a surgeon for oral and maxillofacial surgery or a dentist Exclusion Criteria: * Previous irradiation in the TMJ area * Age below 50 years
Where it's running
-
Medical University of Vienna
Vienna, Austria Recruiting
Study contacts
- Study coordinator: Cora Waldstein, MD
- Email: Cora.waldstein@meduniwien.ac.at
- Phone: 004314040026920
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Steatotic Liver Disease in Austria: A Long-Term Registry and Biobank
This registry will follow adults with suspected or confirmed steatotic liver disease in Austria to learn about how the disease progresses and which non-invasive tests best predict outcomes.
-
Kidney fibrosis imaging with Ga-68 FAPI PET/CT in CKD
This study tests whether a Ga-68 FAPI PET/CT scan can reflect how much fibrosis is in the kidneys of people with chronic kidney disease.
-
Myo-Inositol for Glycemic Control in Gestational Diabetes
This study tests whether taking myo-inositol with folic acid can improve blood sugar control and reduce inflammation in pregnant people with gestational diabetes.
-
BAL balance: ARDS through lung lavage and imaging to find different ARDS types
This study tests how bronchoalveolar lavage fluid and chest CT imaging can reveal different ARDS subtypes in adults with ARDS or severe pneumonia in the ICU.
-
Does a CDT level at ICU admission predict short-term outcomes in critically ill adults?
This study tests whether high carbohydrate-deficient transferrin levels at ICU admission can predict worse short-term outcomes for adults with critical illness from emergency department admissions.
-
Personalized Targeted Glioblastoma Therapies Guided by Ex Vivo Drug Screening
This trial tests whether using a patient’s own tumor cells to screen drugs can guide a personalized treatment plan for people with newly diagnosed glioblastoma undergoing short-course radiotherapy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.